Hybrids of privileged structures benzothiazoles and pyrrolo[2,1-c] [1,4]benzodiazepin-5-one, and diversity-oriented synthesis of benzothiazoles.

Privileged structures like Benzothiazole and Pyrrolobenzodiazepine offer wonderful opportunity to explore in anti-cancer drug discovery as a mean to counter drug-resistance problem. BT-PBD hybrids and diverse BT derivatives have been synthesized and their in vitro cytotoxic activities were screened against five cancer cell lines have been discussed. The novel compounds showed promising results as compared with the marketed drug etoposide and could well be used in future anti-cancer drug development studies.

[1]  E. Akı-Şener,et al.  Synthesis and structure-activity relationships of new antimicrobial active multisubstituted benzazole derivatives. , 2004, European journal of medicinal chemistry.

[2]  Stuart L. Schreiber,et al.  Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays , 2002, Nature.

[3]  S. A. El‐Hawash,et al.  Synthesis of some novel benzoxazole derivatives as anticancer, anti-HIV-1 and antimicrobial agents. , 2005, European journal of medicinal chemistry.

[4]  Chi V Dang,et al.  Cancer's molecular sweet tooth and the Warburg effect. , 2006, Cancer research.

[5]  P. Arya,et al.  Natural product-like chemical space: search for chemical dissectors of macromolecular interactions. , 2005, Current opinion in chemical biology.

[6]  S. Schreiber,et al.  Macrolactones in diversity-oriented synthesis: preparation of a pilot library and exploration of factors controlling macrocyclization. , 2004, Journal of combinatorial chemistry.

[7]  D. Thurston,et al.  Synthesis of DNA-interactive pyrrolo[2,1-c][1,4]benzodiazepines (PBDs). , 1994, Chemical reviews.

[8]  H. Sugimoto,et al.  Synthesis of 3,3,3-trifluoroprop-1-enyl compounds from some enolizable aldehydes , 2004 .

[9]  M. V. Sargent,et al.  Tetrabutylammonium permanganate: an efficient oxidant for organic substrates , 1978 .

[10]  K. Drauz,et al.  A convenient reduction of amino acids and their derivatives , 1993 .

[11]  A. Drzezga,et al.  Metabolically stabilized benzothiazoles for imaging of amyloid plaques. , 2007, Journal of medicinal chemistry.

[12]  L. Goodman,et al.  Potential Anticancer Agents.1 LXX. Some Simple Derivatives of the Actinomycins , 1962 .

[13]  H. Pelicano,et al.  Glycolysis inhibition for anticancer treatment , 2006, Oncogene.

[14]  E. Sausville,et al.  The antitumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces NF-κB activity in drug-sensitive MCF-7 cells , 2005, Anti-cancer drugs.

[15]  Bernd Becker,et al.  Carbohydrates as Scaffolds in Drug Discovery , 2006, ChemMedChem.

[16]  R. Aft,et al.  Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death , 2002, British Journal of Cancer.

[17]  D Subhas Bose,et al.  Diversity-oriented synthesis of quinolines via Friedländer annulation reaction under mild catalytic conditions. , 2010, Journal of combinatorial chemistry.

[18]  Nancy Torres,et al.  Synthesis and activity of novel benzoxazole derivatives of mannopeptimycin glycopeptide antibiotics. , 2003, Bioorganic & medicinal chemistry letters.

[19]  M. K. Gurjar,et al.  Stereospecific synthesis of a novel azetido[2,1-c][1,4]-benzodiazepine (ABD) ring system with DNA recognition potential , 1997 .

[20]  A. Tripathi,et al.  Diversity oriented synthesis of tricyclic compounds from glycals using the Ferrier and the Pauson-Khand reactions. , 2005, Journal of combinatorial chemistry.

[21]  S. Lippard,et al.  Cisplatin and DNA repair in cancer chemotherapy. , 1995, Trends in biochemical sciences.

[22]  S. Schreiber,et al.  Pairwise use of complexity-generating reactions in diversity-oriented organic synthesis. , 2000, Organic letters.

[23]  J. R. Hoover,et al.  Pyrrolo[1,4]benzodiazepine antitumor antibiotics: relationship of DNA alkylation and sequence specificity to the biological activity of natural and synthetic compounds. , 1988, Chemical research in toxicology.

[24]  S. Schreiber,et al.  Target-oriented and diversity-oriented organic synthesis in drug discovery. , 2000, Science.

[25]  D. Langley,et al.  O-Debenzylation of a Pyrrolo[2,1-c][1,4]benzodiazepine in the Presence of a Carbinolamine Functionality: Synthesis of DC-81 , 1990 .

[26]  Brian J Bacskai,et al.  A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. , 2002, Bioorganic & medicinal chemistry letters.

[27]  D. Langley,et al.  A versatile and efficient synthesis of carbinolamine-containing pyrrolo[1,4]benzodiazepines via the cyclization of N-(2-aminobenzoyl)pyrrolidine-2-carboxaldehyde diethyl thioacetals: total synthesis of prothracarcin , 1987 .

[28]  Douglas A. Horton,et al.  The combinatorial synthesis of bicyclic privileged structures or privileged substructures. , 2003, Chemical reviews.

[29]  Laurence H. Hurley,et al.  DNA and its associated processes as targets for cancer therapy , 2002, Nature Reviews Cancer.

[30]  M. Idrees,et al.  An efficient and high yielding protocol for the synthesis of substituted dihydropyrimidin‐2(1h)‐ones and spiro‐fused heterocycles by involving tandem reactions , 2007 .

[31]  M. Periasamy,et al.  Selective reduction of carboxylic acids into alcohols using sodium borohydride and iodine , 1991 .

[32]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[33]  H. Lehrach,et al.  Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D. Thurston,et al.  SYNTHESIS OF DNA-INTERACTIVE PYRROLO2,1-C1,4BENZODIAZEPINES , 1994 .

[35]  Stuart L Schreiber,et al.  Towards the optimal screening collection: a synthesis strategy. , 2008, Angewandte Chemie.

[36]  J. Crivello.  Nitrations and oxidations with inorganic nitrate salts in trifluoroacetic anhydride , 1981 .

[37]  S. Sakaguchi,et al.  An Alternative Method for the Selective Bromination of Alkylbenzenes Using NaBrO(3)/NaHSO(3) Reagent. , 1998, The Journal of organic chemistry.

[38]  Sivaraman Dandapani,et al.  Current strategies for diversity-oriented synthesis. , 2010, Current opinion in chemical biology.

[39]  S. Yamazaki.  Chromium(VI) Oxide-Catalyzed Benzylic Oxidation with Periodic Acid , 1999 .

[40]  P. Williams,et al.  Lucentamycins A-D, cytotoxic peptides from the marine-derived actinomycete Nocardiopsis lucentensis. , 2007, Journal of natural products.

[41]  M. Wills,et al.  Asymmetric organocatalysis of the addition of acetone to 2-nitrostyrene using N-diphenylphosphinyl-1,2-diphenylethane-1,2-diamine (PODPEN) , 2010 .

[42]  M. Stevens,et al.  Antitumor benzothiazoles. 16. Synthesis and pharmaceutical properties of antitumor 2-(4-aminophenyl)benzothiazole amino acid prodrugs. , 2002, Journal of medicinal chemistry.

[43]  M. Idrees,et al.  Dess-Martin PeriodinaneMediated Intramolecular Cyclization of Phenolic Azomethines: A Solution-PhaseStrategy toward Benzoxazoles and Benzothiazoles , 2010 .

[44]  G. Giacomelli,et al.  A mild and efficient alternative to the classical Swern oxidation. , 2001, The Journal of organic chemistry.

[45]  Stuart L Schreiber,et al.  Diversity-oriented synthesis of biaryl-containing medium rings using a one bead/one stock solution platform. , 2002, Journal of the American Chemical Society.

[46]  B. E. Evans,et al.  Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. , 1988, Journal of Medicinal Chemistry.

[47]  Diversity-oriented synthesis of azaspirocycles. , 2004, Organic letters.

[48]  K. Ochiai,et al.  Pyrronamycin A and B, novel antitumor antibiotics containing pyrrole-amide repeating unit, produced by Streptomyces sp. , 2000, The Journal of antibiotics.

[49]  Hye-Sook Kim,et al.  Preparation of quinoline hexose analogs as novel chloroquine-resistant malaria treatments (1). Synthesis of 4-hydroxyquinoline-beta-glucosides. , 2007, Chemical & pharmaceutical bulletin.

[50]  R. V. van Breemen,et al.  Cimipronidine, a cyclic guanidine alkaloid from Cimicifuga racemosa. , 2005, Journal of natural products.

[51]  W. Klunk,et al.  Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. , 2003, Journal of medicinal chemistry.

[52]  S. Neidle,et al.  Synthesis of Sequence-Selective C8-Linked Pyrrolo[2,1-c][1,4]benzodiazepine DNA Interstrand Cross-Linking Agents. , 1996, The Journal of organic chemistry.

[53]  M. Idrees,et al.  Hypervalent iodine mediated intramolecular cyclization of thioformanilides: expeditious approach to 2-substituted benzothiazoles. , 2006, The Journal of organic chemistry.

[54]  Stuart L Schreiber,et al.  Skeletal diversity via a folding pathway: synthesis of indole alkaloid-like skeletons. , 2005, Organic letters.

[55]  S. Schreiber,et al.  Synthetic strategy toward skeletal diversity via solid-supported, otherwise unstable reactive intermediates. , 2004, Angewandte Chemie.

[56]  E. Stone,et al.  Antitumor benzothiazoles. 26.(1) 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines. , 2006, Journal of medicinal chemistry.

[57]  Derek S. Tan,et al.  Diversity-oriented synthesis: exploring the intersections between chemistry and biology , 2005, Nature chemical biology.